NPHLA Daily
NPHLA Daily
Thursday, October 15, 2026 · 4-minute read
Good morning. Here is what changed across metabolic medicine, pharmacy regulation, aesthetics and healthcare technology since yesterday — every item linked to its source.
Top development today
What changed today in AI & Technology: 3 new studies
NPHLA tracked 3 new official records on this desk today: 3 new studies. First: New research in World journal of urology: “Ambient artificial intelligence scribes in urology: a pilot evaluation of user experience and clinical efficiency gains”.
Metabolic signal
What changed today in Metabolic: 2 trial updates, 1 new study
NPHLA tracked 3 new official records on this desk today: 2 trial updates, 1 new study. First: New trial registered: FutureShape Family
Regulatory signal
What changed today in Regulatory: 2 safety alerts
NPHLA tracked 2 new official records on this desk today: 2 safety alerts. First: Convenience Kit Recall: AVID Medical Removes Convenience Kits Affected by BD ChloraPrep Applicator Recall
AI & Technology signal
Ambient artificial intelligence scribes in urology: a pilot evaluation of user experience and clinical efficiency gains
From World journal of urology.
One thing worth watching
Comments close: Agency Information Collection Activities; Proposed Collection; Comment Request; Registration of Human Drug Compounding Outsourcing Facilities Under the Federal Food, Drug, and…
October 29, 2026 — verified from the Federal Register comments_close_on.
5 things to know
- What changed today in AI & Technology: 3 new studies
- What changed today in Metabolic: 2 trial updates, 1 new study
- What changed today in Regulatory: 2 safety alerts
- What changed today in Metabolic: 1 new study
- New trial registered: FutureShape Family (ClinicalTrials.gov (U.S. National Library of Medicine))
Compiled by NPHLA Intelligence from published briefings and official records. Professional information only — not medical or legal advice. Our standards.